本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Estrella Immunopharma

0.8445
+0.02442.98%
成交量:1,747.00
成交额:1,477.38
市值:3,054.18万
市盈率:-2.95
高:0.8599
开:0.8300
低:0.8300
收:0.8201
数据加载中...
2024/07/02

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/09

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/31

重要事件披露

Form 8-K - Current report
2023/12/28

SEC问询函

Form CORRESP - Correspondence
2023/12/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/16

SEC问询函

Form CORRESP - Correspondence
2023/11/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/14

SEC问询函

Form CORRESP - Correspondence
2023/11/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/30

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/10/05

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/10/05

重要事件披露

Form 8-K - Current report